| PIRCISLY PROMETHEUS BIOSCIENCES INC.
2275558 09 Mar 2023 | on 29 Oct 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use. Class 042 Class 042 Computer & Software Services & Scientific Services Medical laboratory services, namely, laboratory testing, medical diagnostic testing for research purposes, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection. Class 044 Medical, Beauty & Agricultural Services Disease management services; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing information via a website about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer. | | 
